Brief: Embecta Q2 Revenue Down 3.4% To $274.5 Mln
May 13 (Reuters) - Embecta Corp EMBC.O :
* . REPORTS SECOND QUARTER AND FIRST SIX MONTHS OF FISCAL
YEAR
2022 FINANCIAL RESULTS AND PROVIDES FINANCIAL GUIDANCE FOR THE
LAST SIX MONTHS OF FISCAL YEAR 2022
* Q2 REVENUE FELL 3.4 PERCENT TO $274.5 MILLION
* FOR LAST SIX MONTHS OF FISCAL YEAR 2022, COMPANY EXPECTS
TOTAL
REVENUE OF APPROXIMATELY $555 MILLION
* QTRLY EARNINGS PER SHARE $1.38
Source text for Eikon: ID:nGNX4Zd5fr
Further company coverage: EMBC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Embecta
See all newsEmbecta Corp. reports results for the quarter ended June 30 - Earnings Summary
Brief: Embecta Reports Third Quarter Fiscal 2026 Financial Results
Brief: Embecta Outlook FY Adjusted EPS USD 0.27 Vs. IBES Estimate USD 1.59
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel